Objective: We reviewed our experience with trimodality management of malign
ant pleural mesothelioma (MPM). Methods: From September 1998 to August 2000
, 32 consecutive patients with histological diagnosis of MPM underwent trim
odality therapy, including surgery followed by adjuvant chemotherapy and ra
diation therapy. Surgery consisted of pleurectomy/decortication (P/D) or pl
eural-pericardial-pneumonectomy and diaphragm (PPPD). Pre-operative staging
according to the Brigham Staging System was accomplished using computed to
mography (CT) and magnetic resonance imaging (MRI); patients with evident e
xtrapleural spread were excluded. Results. Our series included 21 men and 1
1 women with a median age of 53.5 years (range 40-69). Histologically, ther
e were 26 epithelial, four mixed and two sarcomatous MPM. Post-surgical sta
ging was as follows: six patients were at Stage I; of these, two received a
P/D and four a PPPD. Ten patients were at Stage Il and all received a PPPD
; 16 patients were at Stage m (under-staged pre-operatively): of these, nin
e patients presented extrapleural lymph node metastases (N2) and all receiv
ed a PPPD, seven patients presented with chest wall or mediastinal invasion
(T4) with macroscopic residual tumour, and ail received a de-bulking P/D.
We observed major complications in ten patients: six bleeding, two respirat
ory insufficiency and two nerve paralysis. There were two perioperative dea
ths (6.25% mortality). Twenty-seven patients out of 30 surviving surgery ha
d a follow-up greater than 6 months; 21 patients out of 27 are alive with a
median follow-up of 12.5 months. Conclusions: (1) Trimodality therapy is f
easible in selected patients with MPM and has an acceptable operative morta
lity rate. (2) Our current pre-operative staging based on CT/MRI looks rath
er inaccurate and needs to be improved. (3) The high rate of post-surgical
N2 patients or with diffusion to the inferior surface of the diaphragm may
suggest the use of routine mediastinoscopy and laparoscopy for a more appro
priate patient selection. (C) 2001 Elsevier Science B.V. All rights reserve
d.